These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 23653850)
1. Urine Monocyte Chemoattractant Protein-1(UMCP-1) as a Biomarker of Renal Involvement in Systemic Lupus Erythematosus. Mirfeizi Z; Mahmoudi M; Naghibi M; Hatef M; Sharifipour F; Jokar M; Zeraati A; Shariati Sarabi Z; Azarian A Iran J Basic Med Sci; 2012 Nov; 15(6):1191-5. PubMed ID: 23653850 [TBL] [Abstract][Full Text] [Related]
2. Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: A case-control study. Dong X; Zheng Z; Luo X; Ding J; Li Y; Li Z; Li S; Rong M; Fu Y; Wu Z; Zhu P Medicine (Baltimore); 2018 Apr; 97(16):e0343. PubMed ID: 29668584 [TBL] [Abstract][Full Text] [Related]
3. Urine Monocyte Chemoattractant Protein-1 and Lupus Nephritis Disease Activity: Preliminary Report of a Prospective Longitudinal Study. Alharazy S; Kong NC; Mohd M; Shah SA; Ba'in A; Abdul Gafor AH Autoimmune Dis; 2015; 2015():962046. PubMed ID: 26246906 [TBL] [Abstract][Full Text] [Related]
4. Urinary Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (uTWEAK) and Urinary Monocyte Chemo-attractant Protein-1 (uMCP-1): Promising Biomarkers of Lupus Nephritis Activity? Elsaid DS; Abdel Noor RA; Shalaby KA; Haroun RA Saudi J Kidney Dis Transpl; 2021; 32(1):19-29. PubMed ID: 34145111 [TBL] [Abstract][Full Text] [Related]
5. Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1. Gouda W; Abd Elaziz Alsaid A; Abbas AS; Abdel-Aziz TM; Shoaeir MZ; Abd Elazem AAS; Sayed MH Open Access Rheumatol; 2022; 14():161-170. PubMed ID: 36133925 [TBL] [Abstract][Full Text] [Related]
6. Combined detection of uMCP-1 and uTWEAK for rapid discrimination of severe lupus nephritis. Dong XW; Zheng ZH; Ding J; Luo X; Li ZQ; Li Y; Rong MY; Fu YL; Shi JH; Yu LC; Wu ZB; Zhu P Lupus; 2018 May; 27(6):971-981. PubMed ID: 29451067 [TBL] [Abstract][Full Text] [Related]
7. The first-year course of urine MCP-1 and its association with response to treatment and long-term kidney prognosis in lupus nephritis. Pérez-Arias AA; Méndez-Pérez RA; Cruz C; Zavala-Miranda MF; Romero-Diaz J; Márquez-Macedo SE; Comunidad-Bonilla RA; García-Rueda CC; Mejía-Vilet JM Clin Rheumatol; 2023 Jan; 42(1):83-92. PubMed ID: 36107264 [TBL] [Abstract][Full Text] [Related]
8. Serum and Urine Monocyte Chemoattractant Protein-1 as A Markers for Lupus Nephritis. Abozaid MA; Ahmed GH; Tawfik NM; Sayed SK; Ghandour AM; Madkour RA Egypt J Immunol; 2020 Jan; 27(1):97-107. PubMed ID: 33180392 [TBL] [Abstract][Full Text] [Related]
9. Analysis of urinary TGF-β1, MCP-1, NGAL, and IL-17 as biomarkers for lupus nephritis. Susianti H; Iriane VM; Dharmanata S; Handono K; Widijanti A; Gunawan A; Kalim H Pathophysiology; 2015 Mar; 22(1):65-71. PubMed ID: 25595582 [TBL] [Abstract][Full Text] [Related]
10. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients. Rosa RF; Takei K; Araújo NC; Loduca SM; Szajubok JC; Chahade WH J Rheumatol; 2012 Oct; 39(10):1948-54. PubMed ID: 22942263 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity. Gupta R; Yadav A; Aggarwal A Clin Rheumatol; 2016 Nov; 35(11):2707-2714. PubMed ID: 27624649 [TBL] [Abstract][Full Text] [Related]
12. The role of urinary biomarker monocyte chemoattractant protein (MCP-1) in correlation with different histopathological classes of lupus nephritis in Egyptian patients. El-Shinnawy H; Mahmoud O; Abdelmohsen W; Ahmed A; Khedr L Egypt J Immunol; 2024 Jan; 31(1):116-123. PubMed ID: 38224276 [TBL] [Abstract][Full Text] [Related]
13. Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare. Singh RG; Usha ; Rathore SS; Behura SK; Singh NK Lupus; 2012 Oct; 21(11):1214-8. PubMed ID: 22759858 [TBL] [Abstract][Full Text] [Related]
14. A study of hepcidin and monocyte chemoattractant protein-1 in Egyptian females with systemic lupus erythematosus. Mohammed MF; Belal D; Bakry S; Marie MA; Rashed L; Eldin RE; El-Hamid SA J Clin Lab Anal; 2014 Jul; 28(4):306-9. PubMed ID: 24578220 [TBL] [Abstract][Full Text] [Related]
15. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis. Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762 [TBL] [Abstract][Full Text] [Related]
16. Association of urinary lipocalin-2 with lupus nephritis. Sharifipour F; Zeraati A; Sahebari M; Hatef M; Naghibi M; Rezaieyazdi Z; Mahmoudi M; Azarian AA; Mirfeizi Z; Samadi K Iran J Basic Med Sci; 2013 Sep; 16(9):1011-5. PubMed ID: 24171081 [TBL] [Abstract][Full Text] [Related]
17. Urinary MCP-1 and TWEAK as non-invasive markers of disease activity and treatment response in patients with lupus nephritis in South Africa. Moloi MW; Rusch JA; Omar F; Ekrikpo U; Dandara C; Bello AK; Jayne D; Okpechi IG Int Urol Nephrol; 2021 Sep; 53(9):1865-1873. PubMed ID: 33459955 [TBL] [Abstract][Full Text] [Related]